The EPS projection of Cigna Corporation (NYSE:CI) for quarter ended 2016-09-30 is $2.45. Last week, the EPS forecast was $2.45 against target of $2.45, a month earlier. Two months ago, this estimate was $2.45 versus forecast of $2.45 three months earlier, implying a deviation of 0%.
Cigna Corporation (NYSE:CI) stated that 18 days ago, its stock price was positively revised 4 times while negative revisions were 3.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 6, 6, and 6, correspondingly.
EPS estimate downgrade for Cigna Corporation (NYSE:CI) in the preceding 30, 120, 60 and 90 days were 0, 1, 1, and 1, correspondingly.
Cigna Corporation (NYSE:CI) EPS target for the quarter closed 1 was $2.45, based on 10 recommendations. As reported on 2016-05-06 the EPS was $2.32. The change was $0.15, implying a percentage deviation of 6.91%. The projections showed a standard deviation of 0.04.
Quarterly Sales Estimates
Cigna Corporation (NYSE:CI) yearly sales prediction for the fiscal 2017 stands at $10072.117 and the median estimate is at $10116.735. Almost 4 analysts issued sales target.
Highest sales target is $10811 while the lowest target is $9244 showing standard deviation of 641.835%.
As many as 4 analysts have sales targets revised upside while 4 reduced sales estimates, implying a deviation of 0%.
Last month, 4 revised sales number projection on upside while 4 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 4 hiked sales target and 4 reduced sales forecast. Cigna Corporation (NYSE:CI) announced that the deviation in forecast was -2.38%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...